dr. Sylvia Snauwaert
Gebruik de knoppen om de artikels, publicaties en presentaties van deze auteur te raadplegen.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood. 2020 Apr 16;135(16):1396-1405. doi: 10.1182/blood.2019003526.PMID: 31978225 Free PMC article. Clinical Trial.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol. 2020 Apr;189(1):84-96. doi: 10.1111/bjh.16300. Epub 2019 Nov 8.PMID: 31702836 Free PMC article.
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.
Haematologica. 2020 May;105(5):1306-1316. doi: 10.3324/haematol.2019.222612. Epub 2019 Aug 1.PMID: 31371409 Free PMC article
Guidelines of the Belgian Hematology Society on the use of stem cell transplantation in lymphoproliferative diseases.
Belgian journal of hematology volume 10 issue 2 march 2019 p 69-79.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol. 2019 Nov 8. doi: 10.1111/bjh.16300. PMID: 31702836
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.
Haematologica. 2019 Aug 1. pii: haematol.2019.222612. doi: 10.3324/haematol.2019.222612. PMID: 31371409
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.
Lancet Haematol. 2019 Aug;6(8):e429-e437. doi: 10.1016/S2352-3026(19)30089-4. Epub 2019 Jul 8. PMID: 31296423
Highlights in lymphoma.
Belgian Journal of Hematology. 2018 Feb; 9(1): 14-18.
Hodgkin’s lymphoma: Belgian Hematology Society guidelines in diagnosis, treatment and follow-up.
Belgian Journal of Hematology. 2018; 9; 214-224.